1. Search Result

Search Result

Results for "143201-11-0" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-109523
    Cerivastatin sodium

    Ferroptosis HMG-CoA Reductase (HMGCR) Cancer Cardiovascular Disease
    Cerivastatin sodium is a synthetic lipid-lowering agent and a highly potent, well-tolerated and orally active HMG-CoA reductase inhibitor, with a Ki of 1.3 nM/L. Cerivastatin sodium reduces low-density lipoprotein cholesterol levels. Cerivastatin sodium also inhibits proliferation and invasiveness of MDA-MB-231 cells, mainly by RhoA inhibition, and has anti-cancer effect.